Skip to content
lifestyle.celebhomes.net
Author:
Vogenx, Inc.
Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia
October 15, 2026
Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
October 9, 2026
Vogenx Appoints Ken Toombs to Board of Directors
September 22, 2026
Vogenx Announces Closing of Initial Public Offering
August 13, 2026
Vogenx Announces Pricing of Initial Public Offering
August 11, 2026